| Icotinib Hydrochloride in Treating Patients With Advanced Cancers (NCT02033148) | Roswell Park Cancer Institute | 2014-08-01 |
| Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT02029417) | Roswell Park Cancer Institute | 2014-07-01 |
| Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma (NCT01959698) | Roswell Park Cancer Institute | 2014-04-17 |
| Cholecalciferol Supplementation in Strengthening Inspiratory Muscles in Cholecalciferol-Deficient Patients With Chronic Obstructive Pulmonary Disease (NCT02877641) | Roswell Park Cancer Institute | 2014-04-16 |
| Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer (NCT02068157) | Roswell Park Cancer Institute | 2014-04-01 |
| Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery (NCT01854684) | Roswell Park Cancer Institute | 2014-02-21 |
| Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens (NCT01948141) | Roswell Park Cancer Institute | 2014-01-30 |
| Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy (NCT01728480) | Roswell Park Cancer Institute | 2014-01-01 |
| Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer (NCT01718223) | Roswell Park Cancer Institute | 2013-12-01 |
| Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission (NCT01982487) | Roswell Park Cancer Institute | 2013-12-01 |
| Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT02072486) | Roswell Park Cancer Institute | 2013-11-18 |
| Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer (NCT01896778) | Roswell Park Cancer Institute | 2013-10-04 |
| Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery (NCT01886235) | Roswell Park Cancer Institute | 2013-09-04 |
| Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer (NCT01876446) | Roswell Park Cancer Institute | 2013-08-29 |
| DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT01834248) | Roswell Park Cancer Institute | 2013-07-30 |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery (NCT01892930) | Roswell Park Cancer Institute | 2013-07-11 |
| Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT01835223) | Roswell Park Cancer Institute | 2013-07-11 |
| Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T (NCT01833208) | Roswell Park Cancer Institute | 2013-07-03 |
| Broccoli Sprout Extract in Treating Patients With Breast Cancer (NCT01753908) | Roswell Park Cancer Institute | 2013-05-21 |
| Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy (NCT01674374) | Roswell Park Cancer Institute | 2013-05-01 |
| Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery (NCT01754519) | Roswell Park Cancer Institute | 2013-05-01 |
| Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma (NCT01744171) | Roswell Park Cancer Institute | 2013-03-26 |
| Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer (NCT01769885) | Roswell Park Cancer Institute | 2013-03-14 |
| Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer (NCT01781741) | Roswell Park Cancer Institute | 2013-03-06 |
| Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination (NCT01292421) | Roswell Park Cancer Institute | 2013-02-01 |
| Biomarkers in Post-Menopausal Women Receiving Flaxseed (NCT01698294) | Roswell Park Cancer Institute | 2012-12-14 |
| Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer (NCT01684397) | Roswell Park Cancer Institute | 2012-11-21 |
| Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers (NCT01771627) | Roswell Park Cancer Institute | 2012-10-22 |
| Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer (NCT01545141) | Roswell Park Cancer Institute | 2012-10-01 |
| Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma (NCT01250470) | Roswell Park Cancer Institute | 2012-09-05 |
| Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT01536054) | Roswell Park Cancer Institute | 2012-08-20 |
| PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic (NCT01540253) | Roswell Park Cancer Institute | 2012-05-01 |
| Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT01550185) | Roswell Park Cancer Institute | 2012-05-01 |
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant (NCT01558778) | Roswell Park Cancer Institute | 2012-05-01 |
| Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors (NCT01573780) | Roswell Park Cancer Institute | 2012-04-01 |
| Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia (NCT01536067) | Roswell Park Cancer Institute | 2012-04-01 |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers (NCT01497392) | Roswell Park Cancer Institute | 2012-03-29 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01529827) | Roswell Park Cancer Institute | 2012-02-28 |
| Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer (NCT01174199) | Roswell Park Cancer Institute | 2012-02-01 |
| Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery (NCT01533948) | Roswell Park Cancer Institute | 2012-01-01 |
| Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery (NCT01527136) | Roswell Park Cancer Institute | 2012-01-01 |
| Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT01527149) | Roswell Park Cancer Institute | 2011-12-06 |
| Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy (NCT01521936) | Roswell Park Cancer Institute | 2011-12-01 |
| Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia (NCT01555268) | Roswell Park Cancer Institute | 2011-10-31 |
| Cholecalciferol and Flu Vaccine in Treating Healthy Participants (NCT01561989) | Roswell Park Cancer Institute | 2011-10-01 |
| Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies (NCT01564277) | Roswell Park Cancer Institute | 2011-09-29 |
| Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery (NCT01093092) | Roswell Park Cancer Institute | 2011-09-01 |
| Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers (NCT01800500) | Roswell Park Cancer Institute | 2011-09-01 |
| Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing Surgery (NCT01597804) | Roswell Park Cancer Institute | 2011-04-01 |
| Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer (NCT01292668) | Roswell Park Cancer Institute | 2011-03-01 |
| Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01246622) | Roswell Park Cancer Institute | 2011-02-07 |
| Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia (NCT01251250) | Roswell Park Cancer Institute | 2010-12-01 |
| Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT01178944) | Roswell Park Cancer Institute | 2010-09-01 |
| High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer (NCT01198548) | Roswell Park Cancer Institute | 2010-08-01 |
| A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx (NCT01140178) | Roswell Park Cancer Institute | 2010-06-08 |
| Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer (NCT00670397) | Roswell Park Cancer Institute | 2010-06-01 |
| Guided Biopsy for Mapping Prostate Cancer (NCT01007214) | Roswell Park Cancer Institute | 2010-05-01 |
| Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis (NCT01014546) | Roswell Park Cancer Institute | 2010-04-01 |
| Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery (NCT01108003) | Roswell Park Cancer Institute | 2010-04-01 |
| Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia (NCT01236417) | Roswell Park Cancer Institute | 2010-03-01 |
| Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate (NCT01582009) | Roswell Park Cancer Institute | 2010-03-01 |
| Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery (NCT01061411) | Roswell Park Cancer Institute | 2010-02-06 |
| Study for the Liquid Chromatography-mass Spectrometry (LC-MS/MS) Assessment of Oxidative DNA Damage in Relation to Antioxidant Usage (NCT01038024) | Roswell Park Cancer Institute | 2010-01-01 |
| Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia (NCT01649791) | Roswell Park Cancer Institute | 2010-01-01 |
| Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients (NCT01027416) | Roswell Park Cancer Institute | 2009-12-14 |
| A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts (NCT01007552) | Roswell Park Cancer Institute | 2009-12-01 |
| Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer (NCT01035437) | Roswell Park Cancer Institute | 2009-12-01 |
| Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma (NCT01032148) | Roswell Park Cancer Institute | 2009-12-01 |
| Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities (NCT02100254) | Roswell Park Cancer Institute | 2009-10-01 |
| Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients (NCT01003678) | Roswell Park Cancer Institute | 2009-10-01 |
| Brody Belt - Alternative Method of Securing a Patient's Urinary Drainage Bag (NCT01228864) | Roswell Park Cancer Institute | 2009-09-22 |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203) | Roswell Park Cancer Institute | 2009-09-01 |
| Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan (NCT01004159) | Roswell Park Cancer Institute | 2009-09-01 |
| Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride (NCT00981162) | Roswell Park Cancer Institute | 2009-08-01 |
| Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment (NCT00942266) | Roswell Park Cancer Institute | 2009-07-01 |
| Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy (NCT01682031) | Roswell Park Cancer Institute | 2009-06-01 |
| Acceptability of Less Harmful Alternatives to Cigarettes (NCT00957424) | Roswell Park Cancer Institute | 2009-06-01 |
| Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation (NCT00887432) | Roswell Park Cancer Institute | 2009-04-08 |
| Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer (NCT01673217) | Roswell Park Cancer Institute | 2009-04-01 |
| Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer (NCT00891904) | Roswell Park Cancer Institute | 2009-04-01 |
| An Alternative Dosing Schedule of Varenicline for Smoking Cessation (NCT00835900) | Roswell Park Cancer Institute | 2009-03-01 |
| Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders (NCT00856388) | Roswell Park Cancer Institute | 2009-01-14 |
| Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment (NCT00851552) | Roswell Park Cancer Institute | 2009-01-01 |
| Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00814164) | Roswell Park Cancer Institute | 2008-12-01 |
| Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance (NCT00796874) | Roswell Park Cancer Institute | 2008-10-01 |
| Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer (NCT00843726) | Roswell Park Cancer Institute | 2008-09-12 |
| Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer (NCT00736645) | Roswell Park Cancer Institute | 2008-08-01 |
| Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer (NCT00736164) | Roswell Park Cancer Institute | 2008-08-01 |
| Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer (NCT00690924) | Roswell Park Cancer Institute | 2008-07-17 |
| Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery (NCT00732563) | Roswell Park Cancer Institute | 2008-07-16 |
| Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (NCT00683787) | Roswell Park Cancer Institute | 2008-05-01 |
| Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx (NCT00675233) | Roswell Park Cancer Institute | 2008-04-25 |
| Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer (NCT00794989) | Roswell Park Cancer Institute | 2008-04-01 |
| Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma (NCT00625183) | Roswell Park Cancer Institute | 2008-03-01 |
| Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis (NCT01014598) | Roswell Park Cancer Institute | 2007-12-04 |
| Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics (NCT00612560) | Roswell Park Cancer Institute | 2007-11-01 |
| Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy (NCT00559481) | Roswell Park Cancer Institute | 2007-10-01 |
| KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment (NCT00646139) | Roswell Park Cancer Institute | 2007-10-01 |
| Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer (NCT00849186) | Roswell Park Cancer Institute | 2007-08-01 |